WallStSmart

Abbott Laboratories (ABT)vsNortech Systems Incorporated (NSYS)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Abbott Laboratories generates 37272% more annual revenue ($46.59B vs $124.65M). ABT leads profitability with a 11.7% profit margin vs 0.8%. NSYS trades at a lower P/E of 32.5x. ABT earns a higher WallStSmart Score of 54/100 (C-).

ABT

Buy

54

out of 100

Grade: C-

Growth: 4.0Profit: 6.0Value: 3.3Quality: 6.0
Piotroski: 4/9Altman Z: 2.71

NSYS

Hold

37

out of 100

Grade: F

Growth: 3.3Profit: 4.0Value: 4.7Quality: 6.5
Piotroski: 3/9Altman Z: 3.02
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

ABTSignificantly Overvalued (-37.5%)

Margin of Safety

-37.5%

Fair Value

$74.13

Current Price

$103.09

$28.97 premium

UndervaluedFair: $74.13Overvalued

Intrinsic value data unavailable for NSYS.

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

ABT2 strengths · Avg: 8.5/10
Market CapQuality
$176.41B9/10

Large-cap with strong market position

Free Cash FlowQuality
$2.09B8/10

Generating 2.1B in free cash flow

NSYS2 strengths · Avg: 10.0/10
Price/BookValuation
0.9x10/10

Reasonable price relative to book value

Altman Z-ScoreHealth
3.0210/10

Safe zone — low bankruptcy risk

Areas to Watch

ABT3 concerns · Avg: 3.3/10
PEG RatioValuation
1.904/10

Expensive relative to growth rate

P/E RatioValuation
33.4x4/10

Premium valuation, high expectations priced in

EPS GrowthGrowth
-47.5%2/10

Earnings declined 47.5%

NSYS4 concerns · Avg: 3.3/10
P/E RatioValuation
32.5x4/10

Premium valuation, high expectations priced in

Market CapQuality
$33.42M3/10

Smaller company, higher risk/reward

Return on EquityProfitability
3.0%3/10

ROE of 3.0% — below average capital efficiency

Profit MarginProfitability
0.8%3/10

0.8% margin — thin

Comparative Analysis Report

WallStSmart Research

Bull Case : ABT

The strongest argument for ABT centers on Market Cap, Free Cash Flow. Revenue growth of 13.0% demonstrates continued momentum.

Bull Case : NSYS

The strongest argument for NSYS centers on Price/Book, Altman Z-Score.

Bear Case : ABT

The primary concerns for ABT are PEG Ratio, P/E Ratio, EPS Growth.

Bear Case : NSYS

The primary concerns for NSYS are P/E Ratio, Market Cap, Return on Equity. Thin 0.8% margins leave little buffer for downturns.

Key Dynamics to Monitor

ABT carries more volatility with a beta of 0.59 — expect wider price swings.

ABT is growing revenue faster at 13.0% — sustainability is the question.

ABT generates stronger free cash flow (2.1B), providing more financial flexibility.

Monitor MEDICAL DEVICES industry trends, competitive dynamics, and regulatory changes.

Bottom Line

ABT scores higher overall (54/100 vs 37/100) and 13.0% revenue growth. Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Abbott Laboratories

HEALTHCARE · MEDICAL DEVICES · USA

Abbott Laboratories is an American multinational medical devices and health care company with headquarters in Abbott Park, Illinois, United States. The company was founded by Chicago physician Wallace Calvin Abbott in 1888 to formulate known drugs; today, it sells medical devices, diagnostics, branded generic medicines and nutritional products. It split off its research-based pharmaceuticals business into AbbVie in 2013.

Visit Website →

Nortech Systems Incorporated

HEALTHCARE · MEDICAL DEVICES · USA

Nortech Systems Incorporated is an electronic manufacturing services company in the United States, Mexico, and China. The company is headquartered in Maple Grove, Minnesota.

Visit Website →

Want to dig deeper into these stocks?